Vimian Group AB (VIMIAN) - Total Assets
Based on the latest financial reports, Vimian Group AB (VIMIAN) holds total assets worth Skr1.11 Billion SEK (≈ $119.43 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Vimian Group AB - Total Assets Trend (2017–2025)
This chart illustrates how Vimian Group AB's total assets have evolved over time, based on quarterly financial data. Also see market value of Vimian Group AB for the company's overall valuation and market capitalisation.
Vimian Group AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Vimian Group AB's total assets of Skr1.11 Billion consist of 19.2% current assets and 80.8% non-current assets. Review VIMIAN current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 5.0% |
| Accounts Receivable | Skr77.20 Million | 7.0% |
| Inventory | Skr80.10 Million | 7.2% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr238.90 Million | 21.5% |
| Goodwill | Skr590.10 Million | 53.2% |
Asset Composition Trend (2017–2025)
This chart illustrates how Vimian Group AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Vimian Group AB stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vimian Group AB's current assets represent 19.2% of total assets in 2025, a decrease from 100.0% in 2017.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 100.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 74.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is goodwill at 53.2% of total assets.
Vimian Group AB Competitors by Total Assets
Key competitors of Vimian Group AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Chemclin Diagnostics Co. Ltd. A
SHG:688468
|
China | CN¥1.76 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$512.35 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Scope Fluidics SA
WAR:SCP
|
Poland | zł141.67 Million |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
IZOTROPIC CORP.
F:1R3
|
Germany | €439.78K |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
Vimian Group AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 1.87 | 1.29 |
| Quick Ratio | 1.22 | 1.22 | 0.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr104.10 Million | Skr104.30 Million | Skr22.81 Million |
Vimian Group AB - Advanced Valuation Insights
This section examines the relationship between Vimian Group AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.91 |
| Latest Market Cap to Assets Ratio | 1.82 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | Skr1.11 Billion |
| Market Capitalization | $2.02 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Vimian Group AB's assets above their book value (1.82x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Vimian Group AB's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Vimian Group AB (2017–2025)
The table below shows the annual total assets of Vimian Group AB from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr1.11 Billion ≈ $119.43 Million |
0.00% |
| 2024-12-31 | Skr1.11 Billion ≈ $119.43 Million |
+13.98% |
| 2023-12-31 | Skr973.68 Million ≈ $104.78 Million |
+5.43% |
| 2022-12-31 | Skr923.56 Million ≈ $99.39 Million |
+44.14% |
| 2021-12-31 | Skr640.72 Million ≈ $68.95 Million |
+40.42% |
| 2020-12-31 | Skr456.29 Million ≈ $49.10 Million |
+360.45% |
| 2019-12-31 | Skr99.10 Million ≈ $10.66 Million |
+198.14% |
| 2018-12-31 | Skr33.24 Million ≈ $3.58 Million |
+664660.00% |
| 2017-12-31 | Skr5.00K ≈ $538.08 |
-- |
About Vimian Group AB
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic… Read more